OKT3

OKT3 is an immmunosupressant drug given to reduce acute rejection in transplant patients.

It acts by blocking the function of T-cells. Side effects include flu-like symptoms due to reduced role of the CD3 cells.

From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.